255 related articles for article (PubMed ID: 33425745)
1. Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.
Zhang R; Li T; Wang W; Gan W; Lv S; Zeng Z; Hou Y; Yan Z; Yang M
Front Oncol; 2020; 10():594098. PubMed ID: 33425745
[TBL] [Abstract][Full Text] [Related]
2. Identification of an IDO1-based immune classifier for survival prediction of upper tract urothelial carcinoma.
Zhong W; Yang M; Cheng S; Hou W; Wang B; Chen J; Yu H; Ouyang Y; Wang X; Ou Z; Xu P; Li X; Zhou L; Huang J; Wang C; Lin T
Cancer Sci; 2022 Mar; 113(3):852-863. PubMed ID: 34962030
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.
Li S; Han X; Lyu N; Xie Q; Deng H; Mu L; Pan T; Huang X; Wang X; Shi Y; Zhao M
Cancer Sci; 2018 Dec; 109(12):3726-3736. PubMed ID: 30264546
[TBL] [Abstract][Full Text] [Related]
4. Changes in Indoleamine 2,3-Dioxygenase 1 Expression and CD8+ Tumor-Infiltrating Lymphocytes after Neoadjuvant Chemoradiation Therapy and Prognostic Significance in Esophageal Squamous Cell Carcinoma.
Zhou S; Yang H; Zhang J; Wang J; Liang Z; Liu S; Li Y; Pan Y; Zhao L; Xi M
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):286-294. PubMed ID: 32004580
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
Sailer V; Sailer U; Bawden EG; Zarbl R; Wiek C; Vogt TJ; Dietrich J; Loick S; Grünwald I; Toma M; Golletz C; Gerstner A; Kristiansen G; Bootz F; Scheckenbach K; Landsberg J; Dietrich D
EBioMedicine; 2019 Oct; 48():341-352. PubMed ID: 31628024
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of immune classification using IDO1 expression in extrahepatic bile duct carcinoma.
Noh BJ; Choi GM; Jang HJ; Ma CH; Oh HS; Kim M; Eom DW
Oncol Lett; 2022 Oct; 24(4):373. PubMed ID: 36238847
[TBL] [Abstract][Full Text] [Related]
8. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
9. miR-448 targets IDO1 and regulates CD8
Lou Q; Liu R; Yang X; Li W; Huang L; Wei L; Tan H; Xiang N; Chan K; Chen J; Liu H
J Immunother Cancer; 2019 Aug; 7(1):210. PubMed ID: 31391111
[TBL] [Abstract][Full Text] [Related]
10. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
11. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
12. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
13. IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
Kiyozumi Y; Baba Y; Okadome K; Yagi T; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H
Ann Surg; 2019 Jun; 269(6):1101-1108. PubMed ID: 31082908
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.
Ma WJ; Wang X; Yan WT; Zhou ZG; Pan ZZ; Chen G; Zhang RX
World J Gastroenterol; 2018 May; 24(20):2181-2190. PubMed ID: 29853736
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of a Unique CD8
Zhang Y; Cui K; Yang Y; Liu B; Zhu M; Chen H; Zhao C; Zhou Y; Nie Y
J Hepatocell Carcinoma; 2023; 10():1051-1067. PubMed ID: 37449280
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.
Ferdinande L; Decaestecker C; Verset L; Mathieu A; Moles Lopez X; Negulescu AM; Van Maerken T; Salmon I; Cuvelier CA; Demetter P
Br J Cancer; 2012 Jan; 106(1):141-7. PubMed ID: 22108515
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating CD8+ T Cells Driven by the Immune Checkpoint-Associated Gene IDO1 Are Associated With Cervical Cancer Prognosis.
Zhang S; Wan J; Chen M; Cai D; Xu J; Chen Q
Front Oncol; 2021; 11():720447. PubMed ID: 34778035
[TBL] [Abstract][Full Text] [Related]
18. The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation.
Schollbach J; Kircher S; Wiegering A; Anger F; Rosenwald A; Germer CT; Löb S
Int J Colorectal Dis; 2020 Feb; 35(2):365-370. PubMed ID: 31828368
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Xu D; Liu X; Wang Y; Zhou K; Wu J; Chen JC; Chen C; Chen L; Zheng J
Biomed Pharmacother; 2020 Jun; 126():109903. PubMed ID: 32113055
[TBL] [Abstract][Full Text] [Related]
20. IDO1 correlates with the immune landscape of head and neck squamous cell carcinoma: a study based on bioinformatics analyses.
Gkountana GV; Wang L; Giacomini M; Hyytiäinen A; Juurikka K; Salo T; Al-Samadi A
Front Oral Health; 2024; 5():1335648. PubMed ID: 38736462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
